Major advantages of the Extroducer
- Passes through the vascular wall directly into the tissue.
- Access to tissue and organs difficult or risky to reach with conventional methods.
- Easy to achieve repeated access.
- Pay loads can be delivered directly to the organ/tissue
Technology and innovation
Smartwise was founded in 2015 to develop the Extroducer technology invented in the laboratory of Staffan Holmin, MD, PhD, CMO of SmartCella.
In 1953, Sven-Ivar Seldinger develop a technique for inserting catheters into the blood vessels via an Introducer. the home of Sven-Ivar Seldinger, who developed the Seldinger, the method used in all hospitals throughout the world to insert catheters into the bloodstream via an Introducer.
Using this as inspiration, Staffan Holmin’s team developed the Extroducer infusion catheter, a novel catheter that uses the same Seldinger principal to exit blood vessels and reach the adjacent tissues. Large animal proof of principal studies at the Karolinska Institutet in tissues, such as heart, kidney, pancreas, and liver, have been performed.
The Extroducer can be integrated with many off-the-shelf microcatheters and navigated into the microvasculature.